Emmanuel Bourinet

Dr. Emmanuel Bourinet

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MMMatteo Elia Mangoni
Matteo Elia Mangoni
BCBrigitte Couette
Brigitte Couette
EBEmmanuel Bourinet
Emmanuel Bourinet
JPJosef Platzer
Josef Platzer
DRDaniel Reimer
Daniel Reimer
JNJoël Nargeot
Joël Nargeot
The spontaneous activity of pacemaker cells in the sino-atrial node (SAN) controls the heart rhythm and rate under physiological conditions. Pacemaker activity in SAN cells is due to the presence of the diastolic depolarization, a slow depolarization phase that drives the membrane voltage from the end of an action potential to the threshold of a new action potential. SAN cells express a wide array of ionic channels, but we have limited knowledge about their functional role in pacemaker activity and we still do not know which channels play a prominent role in the generation of the diastolic depolarization. It is thus important to provide genetic evidence linking the activity of genes coding for ionic channels to specific alterations of pacemaker activity of SAN cells. Here, we show that target inactivation of the gene coding for α 1D (Ca v 1.3) Ca 2+ channels in the mouse not only significantly slows pacemaker activity but also promotes spontaneous arrhythmia in SAN pacemaker cells. These alterations of pacemaker activity are linked to abolition of the major component of the L-type current ( I Ca,L ) activating at negative voltages. Pharmacological analysis of I Ca,L demonstrates that Ca v 1.3 gene inactivation specifically abolishes I Ca,L in the voltage range corresponding to the diastolic depolarization. Taken together, our data demonstrate that Ca v 1.3 channels play a major role in the generation of cardiac pacemaker activity by contributing to diastolic depolarization in SAN pacemaker cells.

1 January 1997 in Nature
Verified
Journal Article
Closed access
GZGerald Zamponi
Gerald Zamponi
EBEmmanuel Bourinet
Emmanuel Bourinet
DNDonald Nelson
Donald Nelson
JNJoel Nargeot
Joel Nargeot
TSTerry P. Snutch
Terry P. Snutch

16 December 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
EBEmmanuel Bourinet
Emmanuel Bourinet
AAAbdelkrim Alloui
Abdelkrim Alloui
AMArnaud Monteil
Arnaud Monteil
CBChristian Barrère
Christian Barrère
BCBrigitte Couette
Brigitte Couette
JNJoël Nargeot
Joël Nargeot
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 1999 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
EBEmmanuel Bourinet
Emmanuel Bourinet
TSTuck Wah Soong
Tuck Wah Soong
KSKathy Sutton
Kathy Sutton
SSSarah Slaymaker
Sarah Slaymaker
EMEleanor Mathews
Eleanor Mathews
TSTerry P. Snutch
Terry P. Snutch

24 March 2011 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
JDJuliette Descoeur
Juliette Descoeur
VPVanessa Pereira
Vanessa Pereira
APAnne Pizzoccaro
Anne Pizzoccaro
AFAmaury Francois
Amaury Francois
BLBing Ling
Bing Ling
EBEmmanuel Bourinet
Emmanuel Bourinet
Cold hypersensitivity is the hallmark of oxaliplatin‐induced neuropathy, which develops in nearly all patients under this chemotherapy. To date, pain management strategies have failed to alleviate these symptoms, hence development of adapted analgesics is needed. Here, we report that oxaliplatin exaggerates cold perception in mice as well as in patients. These symptoms are mediated by primary afferent sensory neurons expressing the thermoreceptor TRPM8. Mechanistically, oxaliplatin promotes over‐excitability by drastically lowering the expression of distinct potassium channels (TREK1, TRAAK) and by increasing the expression of pro‐excitatory channels such as the hyperpolarization‐activated channels (HCNs). These findings are corroborated by the analysis of TREK1‐TRAAK null mice and use of the specific HCN inhibitor ivabradine, which abolishes the oxaliplatin‐induced cold hypersensibility. These results suggest that oxaliplatin exacerbates cold perception by modulating the transcription of distinct ionic conductances that together shape sensory neuron responses to cold. The translational and clinical implication of these findings would be that ivabradine may represent a tailored treatment for oxaliplatin‐induced neuropathy.

1 January 2014 in Physiological Reviews
Verified
Journal Article
Closed access
PDF file
EBEmmanuel Bourinet
Emmanuel Bourinet
CAChristophe Altier
Christophe Altier
MHMichael E. Hildebrand
Michael E. Hildebrand
TTTuan Trang
Tuan Trang
MSMichael W. Salter
Michael W. Salter
GZGerald Zamponi
Gerald Zamponi
The detection and processing of painful stimuli in afferent sensory neurons is critically dependent on a wide range of different types of voltage- and ligand-gated ion channels, including sodium, calcium, and TRP channels, to name a few. The functions of these channels include the detection of mechanical and chemical insults, the generation of action potentials and regulation of neuronal firing patterns, the initiation of neurotransmitter release at dorsal horn synapses, and the ensuing activation of spinal cord neurons that project to pain centers in the brain. Long-term changes in ion channel expression and function are thought to contribute to chronic pain states. Many of the channels involved in the afferent pain pathway are permeable to calcium ions, suggesting a role in cell signaling beyond the mere generation of electrical activity. In this article, we provide a broad overview of different calcium-permeable ion channels in the afferent pain pathway and their role in pain pathophysiology.